What is the recommended clinical intervention when mucopurulent cervicitis is suspected?

What is the recommended clinical intervention when mucopurulent cervicitis is suspected?

• A. Obtain a culture for gonococcus and Chlamydia
• B. Schedule a Pap smear
• C. Perform a transvaginal ultrasound
• D. Begin empiric broad-spectrum antibiotics without testing

Answer: (A)

Suspecting mucopurulent cervicitis means you’re looking for the pathogens that most commonly cause this presentation, principally Neisseria gonorrhoeae and Chlamydia trachomatis. The best next step is to obtain samples from the cervix for culture to detect these organisms (and, in modern practice, nucleic acid amplification testing from the cervix is commonly used as well). This confirms the infection and guides appropriate targeted therapy, which is important for reducing complications and preventing transmission. A Pap smear targets cervical cell changes and screening for dysplasia, not acute infection. A transvaginal ultrasound isn’t indicated for diagnosing cervicitis. Starting empiric broad-spectrum antibiotics without testing can miss the exact pathogen, contribute to antibiotic resistance, and may not provide optimal coverage for gonorrhea, especially with resistant strains. Testing first allows you to tailor treatment and manage contacts appropriately.

Suspecting mucopurulent cervicitis means you’re looking for the pathogens that most commonly cause this presentation, principally Neisseria gonorrhoeae and Chlamydia trachomatis. The best next step is to obtain samples from the cervix for culture to detect these organisms (and, in modern practice, nucleic acid amplification testing from the cervix is commonly used as well). This confirms the infection and guides appropriate targeted therapy, which is important for reducing complications and preventing transmission.

A Pap smear targets cervical cell changes and screening for dysplasia, not acute infection. A transvaginal ultrasound isn’t indicated for diagnosing cervicitis. Starting empiric broad-spectrum antibiotics without testing can miss the exact pathogen, contribute to antibiotic resistance, and may not provide optimal coverage for gonorrhea, especially with resistant strains. Testing first allows you to tailor treatment and manage contacts appropriately.